Genetic aspects of fibrodysplasia ossificans progressiva.
Open Access
- 1 February 1982
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 19 (1) , 35-39
- https://doi.org/10.1136/jmg.19.1.35
Abstract
Complete ascertainment of fibrodysplasia ossificans progressiva in the United Kingdom was attempted and 44 patients were identified. This indicates a point prevalence of 0.61 x 10(-6). The disease is determined as an autosomal dominant trait which has complete penetrance but variable expressivity. No evidence for genetic heterogeneity was found in this series. All patients represented fresh gene mutations and their biological fitness was zero. Geographical clustering of these new mutations was evident but conformed to the general population distribution. The direct estimate of the mutation rate was 1.8 (SE +/- 1.04) x 10(-6) mutations per gene per generation. A significant paternal age effect was evident for these new mutations in the United Kingdom.This publication has 12 references indexed in Scilit:
- Paternal age effect in fibrodysplasia ossificans progressiva.Journal of Medical Genetics, 1979
- Older paternal age and fresh gene mutation: Data on additional disordersThe Journal of Pediatrics, 1975
- Parental age effects on the occurrence of new mutations for the Marfan syndromeAnnals of Human Genetics, 1972
- Zur Genetik der Myositis ossificans progressivaHuman Genetics, 1967
- Renewal of spermatogonia in manJournal of Anatomy, 1966
- CONGENITAL ANIRIDIA1960
- Apert's syndrome (a type of acrocephalosyndactyly)–observations on a British series of thirty‐nine cases*Annals of Human Genetics, 1959
- MARFAN'S SYNDROME IN NORTHERN IRELAND: AN ACCOUNT OF THIRTEEN FAMILIESAnnals of Human Genetics, 1958
- Early myositis ossificans progressiva occurring in homozygotic twins: A clinical and pathologic studyThe Journal of Pediatrics, 1957
- A CONTRIBUTION TO THE STUDY OF MYOSITES OSSIFICIANS PROGRESSAAnnals of Surgery, 1918